Alert detail
LCD L39927: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms — Noridian
What changed
New LCD for myeloproliferative neoplasm testing impacts billing.
Who’s affected: Hematology billing teams · Effective: August 17, 2025
Affected codes
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 17 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.